Monday, April 18, 2016

Temecula’s ZEBRASCI, Inc.
FLEX P Particle Imaging System

TEMECULA, Calif., Monday, April 18, 2016 – Temecula-based medical technology firm Zebrasci, Inc., recently announced their latest product the FLEX P Particle Imaging System.

The Flex P is validated to resolve quantity of particles and distribution of sizes non-destructively in containers. This system is sensitive to count and track subvisible and visible particles in solution. The tracking algorithms are important so that the machine has reduced double counting as well as particle in solution can be characterized where other vision systems are fooled by particle and surface defects on the container. Also tracking algorithms are important so that air bubbles are not considered particles. The Flex P system is designed to accommodate a range of common primary container sizes without changing parts. The optics and automation at the heart of the Flex P system are the same as our higher speed satellite system, but are designed to be compact and well suited for lab environments.

“We are proud of our Zebrasci TEAM that developed the FLEX P,” said Rob Schultheis, CEO/President of Zebrasci, Inc. “With the increased demand for better imaging technology, the FLEX P will enable us to meet the needs of our industry not only here in our lab, but in labs and factories all over the world.”

Since it was founded, Zebrasci, Inc has established a reputation for being on the leading edge of technology in the biotechnology, pharmaceutical, and medical device industries. Through innovative products and strategic partnerships, Zebrasci customers are better able to meet FDA requirements.

About ZebraSci, Inc:
Comprised of cross functional teams of engineers and scientists passionate about developing new technologies in support of combination products, ZebraSci is dedicated to developing innovative and advanced products and solutions for the Biotechnology, Pharmaceutical, and Medical Device industries. Combining quality and innovation, our products integrate proprietary technology and software to support commercialization of combination for the pharmaceutical and biotechnology industry. Visit for more information.